2017 ESGE Guidelines on Colorectal Polypectomy and EMR Call For Tattooing All Lesions

European Society of Gastrointestinal Endoscopy released 2017 practice management guidelines for colorectal polypectomy and endoscopic mucosal resection (EMR) which call for tattooing all lesions for future colonoscopy or surgery.

New guidelines from the European Society of Gastrointestinal Endoscopy (ESGE) detail the latest thinking in colorectal polypectomy and endoscopic mucosal resection (EMR) based on published clinical evidence. Among their recommendations on when and how to prepare and conduct therapeutic colonoscopy procedures includes specific guidance on when and how to tattoo as a standard of care.

“Colonoscopic tattooing is performed to enable future identification, at colonoscopy or surgery, of malignant lesions (proven or suspected), polypectomy, EMR, or ESD sites, difficult-to-detect polyps, or dysplastic areas. All such lesions, other than those definitely located in the cecum, adjacent to the ileocecal valve, or in the low rectum, should be tattooed.”1

Spot® Endoscopic Marker has more than 25 published clinical studies showing the value of post-polypectomy clinical surveillance for future identification of lesions and surgical localization. These guidelines provide a clear summary of these data for Endoscopists and guidance on when to tattoo; All lesions that will need future colonoscopy or surgery should be tattooed.

Read the 2017 ESGE Guidelines Here

Learn more about Spot Endoscopic Marker